The circulating levels of IL-6, IL-8, and tumour necrosis factor alpha (TNF-α) distinguished patients with obesity and lean controls but did not distinguish patients with and without NASH (Figure 2c). The gene discussed is CXCL8; the disease is metabolic dysfunction-associated steatohepatitis.